Envestnet Asset Management Inc. raised its stake in shares of Danaher Co. (NYSE:DHR) by 8.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 473,332 shares of the conglomerate’s stock after buying an additional 37,781 shares during the period. Envestnet Asset Management Inc. owned approximately 0.07% of Danaher worth $68,363,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Amundi Pioneer Asset Management Inc. boosted its holdings in Danaher by 1.5% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 2,719,833 shares of the conglomerate’s stock valued at $359,071,000 after purchasing an additional 40,874 shares during the last quarter. Dorsey Wright & Associates boosted its holdings in Danaher by 1.5% in the second quarter. Dorsey Wright & Associates now owns 32,512 shares of the conglomerate’s stock valued at $4,647,000 after purchasing an additional 467 shares during the last quarter. WINTON GROUP Ltd boosted its holdings in Danaher by 255.9% in the second quarter. WINTON GROUP Ltd now owns 16,441 shares of the conglomerate’s stock valued at $2,350,000 after purchasing an additional 11,821 shares during the last quarter. KAMES CAPITAL plc purchased a new stake in Danaher in the second quarter valued at $2,868,000. Finally, Empirical Finance LLC purchased a new stake in Danaher in the second quarter valued at $212,000. 78.44% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts have commented on DHR shares. ValuEngine lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Argus upped their price target on shares of Danaher to $165.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Wolfe Research set a $157.00 price target on shares of Danaher and gave the company a “buy” rating in a report on Thursday, September 26th. Royal Bank of Canada set a $134.00 target price on shares of Danaher and gave the stock a “hold” rating in a research note on Friday, July 19th. Finally, Piper Jaffray Companies increased their target price on shares of Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research note on Thursday, July 18th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $146.29.
DHR stock opened at $138.01 on Friday. The company’s 50-day simple moving average is $141.25 and its 200-day simple moving average is $137.63. The company has a quick ratio of 1.91, a current ratio of 2.32 and a debt-to-equity ratio of 0.33. Danaher Co. has a 52-week low of $94.59 and a 52-week high of $147.33. The firm has a market cap of $98.83 billion, a P/E ratio of 30.53, a PEG ratio of 2.30 and a beta of 0.94.
Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.04. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business had revenue of $5.16 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same period in the prior year, the company posted $1.15 EPS. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. On average, analysts anticipate that Danaher Co. will post 4.78 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.49%. The ex-dividend date is Thursday, September 26th. Danaher’s payout ratio is currently 15.04%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: What is a Roth IRA?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.